Available datapackage for study 'A Randomized, Double Blind, Placebo Controlled, Multicenter Phase III Study of Regorafenib in Patients With Hepatocellular Carcinoma (HCC) After Sorafenib'

Name: Available datapackage for study 'A Randomized, Double Blind, Placebo Controlled, Multicenter Phase III Study of Regorafenib in Patients With Hepatocellular Carcinoma (HCC) After Sorafenib'
Creator: Vivli
Published: 2025-01-06 16:17:13
License: 暂无描述

DataCite Commons2025-01-06 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00008416.0

下载链接

链接失效反馈

官方服务：

资源简介：

The objective of this study was to evaluate efficacy and safety of regorafenib in patients with advanced liver cancer who had progressed after sorafenib treatment. Patients were treated with regorafenib or placebo using a 2:1 randomization scheme.

提供机构：

Vivli

创建时间：

2022-12-13